Drug recall · February 1, 2017
Albuterol Sulfate Inhalation Solution recall
Why: Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories Inc., Corona, CA 92880 USA, Mfd. by Cipla Ltd. Verna, Goa India, NDC 0591-3467-53
- Lots / codes
Lot #: GA51265, Ex[p. Jan-2017, GA51454, GA51553, GA51583, Exp. Feb-2017, GA51598, GA51724, GA51725, GA51749, Exp. Mar-2017
- Quantity
- 164,844 units
- Company
- Actavis Inc, Parsippany, NJ
- Distribution
- Nationwide in the US
- Initiated
- January 12, 2017 · Voluntary: Firm initiated
- Classified
- January 24, 2017
- Reported
- February 1, 2017
- Ended
- March 5, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Albuterol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.